A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Clinical trial NCT04853251 · RECRUITING
Trial details
- NCT number
- NCT04853251
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2027-07-30
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.